Erlotinib vs Hydroxychloroquine
Erlotinib vs Hydroxychloroquine: Overview
This comparison examines the pharmacological differences between Erlotinib and Hydroxychloroquine.
Mechanism of Action
Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.
Hydroxychloroquine: Accumulates in lysosomes raising pH; inhibits toll-like receptor signaling.
Pharmacokinetics
Half-life: Erlotinib β 36 hours; Hydroxychloroquine β 40-50 days.
Chemical Properties
Molecular Formula: Erlotinib β C22H23N3O4; Hydroxychloroquine β C18H26ClN3O.
Molecular Weight: Erlotinib β 393.4380 g/mol; Hydroxychloroquine β 335.8720 g/mol.
Type: Erlotinib β Small molecule; Hydroxychloroquine β Small molecule.